
Funding
Isomorphic Labs Raises $5B Series C For AI Drug Clinical Trials
17 Nov 2026, 8:20 pm · 3d ago · 1 min read · TechCrunch AI
- Amount
- $5B
- Stage
- Series C
Isomorphic Labs, the AI-driven drug discovery venture spun out of Google's DeepMind in 2021, has secured $5 billion in a Series C funding round. The company plans to use the fresh capital to advance its computational drug design candidates into clinical trials. Spun off to commercialize DeepMind's AlphaFold breakthroughs, Isomorphic Labs partners with leading pharmaceutical companies to accelerate the identification and optimization of small molecules and biologics. This massive funding marks one of the largest capital infusions in the computational biology sector, accelerating the shift toward artificial intelligence-driven therapeutics and biomedical development globally.